tirzepatide or semaglutide Addressing the Weight Loss Injectable Shortage: Exploring Compounded and – Skippack Pharmacy Semaglutide vs. Tirzepatide for Weight

Ozempic is approved by the FDA for the treatment of type 2 diabetes

But aside from its ability to lower glucose levels, Ozempic is also said to have important effects on weight loss for many of its users which has increased interest in the drug, especially from patients suffering from obesity since there have been cases of massive weight loss due to the drug

In another part of the study testing 20-mg, 5-mg, and 1.25-mg doses of amycretin, patients also experienced substantial weight loss, but with overlapping weight-loss curves

Both can legally compound semaglutide under narrow circumstances, but neither produces an FDA approved version of the drug

Have cardiovascular disease, high cholesterol, or elevated homocysteine levels